|
|
|
|
|
by dbmikus
3085 days ago
|
|
Living healthier for longer will not help the healthcare crisis if the tail-end of life has the same health distribution. I think healthspan is a more important first target that lifespan. It's great to see some targeted support for bio, though! It seems like a harder market division to get into than a pure tech company. |
|
https://doi.org/10.1006/jtbi.2001.2430
You will see that there is no good way to compress the tail end of mortality and consequences resulting from accumulated unrepaired damage. The only cost-effective path is to postpone it indefinitely through periodic repair of that damage.
Aging is damage, and mortality/disability rises with damage. Effective treatments for aging are forms of repair of damage, of which only senolytics presently exist in any form that is available. Once you accept this model, you can start to reason about the effects of various approaches, and everything makes a lot more sense.